Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients?

Jain, Tarun Kumar; Singh, Guman; Goyal, Sumit; Yadav, Ajay; Yadav, Dinesh; Khunteta, Nitin; Malhotra, Hemant

Jain, Tarun Kumar; Singh, Guman; Goyal, Sumit; Yadav, Ajay; Yadav, Dinesh; Khunteta, Nitin; Malhotra, Hemant.

Afiliación

Jain TK; Department of Nuclear Medicine, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Singh G; Department of Radiation Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Goyal S; Department of Radiation Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Yadav A; Department of Medical Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Yadav D; Department of Surgical Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Khunteta N; Department of Surgical Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Malhotra H; Department of Medical Oncology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.

World J Nucl Med ; 20(2): 164-171, 2021.

Article en En | MEDLINE | ID: mdl-34321969

Palabras clave

Fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography; laryngeal carcinoma; metabolic biopsy; metachronous second primary; receiver operating characteristic analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Nucl Med Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google